Research will continue toward the value and medical necessity of both WES and WGS where results directly influence medical management and clinical outcomes. As a result, reimbursement for the uses of these testing methods may be changing as more about their roles is learned.
Because of the increased number of risk adjustment programs, improved diagnosis and treatment of chronic kidney disease (CKD) could trigger substantial financial benefit. This research maps a path for physicians and health systems to better utilize existing medications for their patients with CKD.
The nuclear medicine hub in Indiana will generate research, discovery, and evidence of the safety and efficacy of radiopharmaceuticals at a time when the FDA recently has approved two molecular imaging drugs for prostate cancer.
A San Francisco-based otolaryngology practice recently implemented genetic-based treatment offerings. Lessons learned here could be used to guide other practice or hospital leaders that are developing a precision medicine strategy.
James Glazier, PhD, is a professor of intelligent systems at the Indiana Luddy School of Informatics, Computing, and Engineering. Dr. Glazier is uncovering new potential in the concept of “digital twins.” His findings were published in Science. What are digital twins and why are they becoming important for precision medicine?
German-based diagnostics company identifies biomarkers that could help reduce sepsis costs, suggests basing a precision medicine initiative in the hospital ICU.
New precision medicine breakthrough will enable 3D printing of medications that are personalized to a specific patient’s needs. Early adopters of precision medicine may find value in this new strategy that is focused on medication management.
Recent research into the human chronobiome has shown that the “normal” circadian rhythm can vary significantly in healthy individuals. This means that chronotherapies which are based on an average individual’s circadian rhythm may not be as efficacious for everyone.
Next generation sequencing can play a role by consolidating testing to a single platform, a potential game changer for community and regional hospitals.
Implications of using beneficial cardiovascular precision medicine-based screening approaches to raise awareness in at-risk populations